title: Effectiveness of corifollitropin alfa used for ovarian stimulation of poor responder patients.
abstract: OBJECTIVE
  To evaluate the efficiency and efficacy of corifollitropin alfa (follicle-stimulating hormone-carboxy terminal peptide) in the treatment of poor responder patients.
  
  
  METHODS
  A total of 85 poor responder patients with a mean age 40.2±3.9 years entered our assisted fertilization program. The patients were prospectively randomized into two groups based on the ovarian stimulation regimen used: group A (study group) (n=42) received clomiphene citrate and corifollitropin alfa for the first 7 days of stimulation followed by recombinant follicle stimulating hormone (rFSH) in a gonadotropin-releasing hormone antagonist protocol, and group B (control group) (n=43) received clomiphene citrate and a daily injection of rFSH in a gonadotropin-releasing hormone antagonist protocol. We analyzed the stimulation outcome, the number of retrieved oocytes, cleaving embryos, and pregnancy and implantation rates as well.
  
  
  RESULTS
  Comparable results were observed between the two groups in terms of demographic data, stimulation outcome, and the number of canceled cycles. There were no differences evident between groups A and B with respect to the number of retrieved oocytes (3.0±0.8 and 2.7±0.7, respectively) and the number of cleaving embryos (1.8±0.6 and 1.7±0.7, respectively). Higher, though not statistically significant, differences were observed in favor of group A compared to group B in terms of pregnancy rate per cycle (19% and 16.3%, respectively), pregnancy rate per transfer (21.6% and 17.9%, respectively), and implantation rate (14.7% and 13.4%, respectively). Also, miscarriage rate was similar between patients treated with corifollitropin alfa and those treated with daily rFSH injection (12.5% and 14.2%, respectively).
  
  
  CONCLUSIONS
  The results show that ovarian stimulation with corifollitropin alfa appears to be as efficacious and efficient as daily injection rFSH regimen to treat patients with poor ovarian response.
authors: One Day Medical Center-IVF Unit, Roma, Italy.
authors: Helmy
authors: H
authors: Selman
authors: One Day Medical Center-IVF Unit, Roma, Italy.
authors: Leonardo
authors: L
authors: Rinaldi
keywords: Long-acting FSH; ovarian response; ovarian stimulation; pregnancy; recombinant FSH